Somatic cell hybridization experiments were carried out to determine whether normal cells have the ability to suppress the transforming effects of a defined oncogene. A nontransformed Chinese hamster embryo fibroblast cell line (CHEF/18-dm2) was used as the normal parent, and a CHEF/18 transfectant carrying the human mutant c-Ha-ras (EJ) oncogene was used as the tumorigenic parent. Selected hybrids (L318 cell lines) were assayed for the presence of EJ DNA, for the p21 product of the c-Ha-ras gene, and for various indices of cell transformation. These hybrids exhibited a fibroblastic morphology similar to the normal parent, although they contained the EJ gene and expressed its p21 protein product at levels comparable with the transformed parent. They had a reduced capacity for anchorage-independent growth (plating efficiency in methylcellulose of <0.3-13%, as compared with >90% for the transformed parent) and decreased tumor-forming ability in athymic mice. These findings show that normal CHEF/18 cells contain suppressor genes capable of inhibiting expression of the transformed phenotype, and tumor-forming ability, in the presence of an activated EJ oncogene.
The cellular homologues of viral transforming genes, called proto-oncogenes, are expressed in many normal tissues and nontumorigenic cell lines (1) , often in a cell-cycle-dependent manner (2) , or in association with cell proliferation (3, 4) . Since some proto-oncogenes induce the transformed phenotype when overexpressed (5, 6) , their action must be well controlled in normal cells. Whether such an endogenous regulatory mechanism can also operate on activated oncogenes, such as the EJ (mutant c-Ha-ras) gene, is as yet unclear.
Somatic cell hybridization studies, involving the fusion of normal and transformed cells, suggest that normal cells do contain tumor suppressor mechanisms (for review, see ref. 7) . For example, we have observed suppression in hybrids of normal and tumorigenic CHEF (Chinese hamster embryo fibroblast) cells (8) and in hybrids of normal and simian virus 40-transformed mouse cells (9) . The suppression observed appears to have a genetic basis, since reemergence of tumorigenicity is associated with chromosome loss (10) . In the case of the anchorage requirement, reversion to the nonsuppressed phenotype has been correlated with the loss of a specific chromosome (11) .
We have initiated studies aimed at determining whether similar suppressor mechanisms are effective in the presence of a dominant-acting transforming gene-namely, the EJ gene. In the studies reported here, we fused normal CHEF/18 cells to an EJ-transformed CHEF/18 derivative.
Our results show that transformation mediated by the activated EJ oncogene can be suppressed by normal cells.
MATERIALS AND METHODS
Cell Culture. The CHEF/18 cell line and its CHEF/18-dm2 derivative (called dm2), which is resistant to thioguanine and ouabain, were described previously (12) . The CHEF/18/EJ-L3 cell line (called L3) was derived from a focus recovered after transfection (13) of CHEF/18 cells with an EcoRI-linearized pSV2-gpt-EJ vector (14) containing the EJ insert (15) . This line contains an average of one copy of the EJ gene per cell (unpublished data).
The growth medium for all cell lines consisted of a minimal essential medium supplemented with 10% fetal calf serum (Hyclone, Sterile Systems, Logan, UT), 2 mM glutamine, 100 units of penicillin/ml, and 100 ,ug of streptomycin/ml. nopterin, thymidine, and ouabain were purchased from Sigma.) Forty-eight hybrid colonies (L318 cell lines) were isolated 2 wk later, the overall frequency of hybrid formation being 1.25 x 10-3. Fifteen of these cell lines grew poorly or appeared unhealthy. The studies reported here were carried out using hybrids -chosen from among the remaining lines, selection being based on nontransformed or fibroblastic morphology, the ability to grow in medium containing mycophenolic acid at 25 ,g/ml (Eli Lilly), and tetraploid DNA content as determined by flow microfluorimetry. Assay for EJ Sequences in Cell DNA. Genomic DNA was extracted as described (17, 18) . Approximately 10 ,ug of DNA was digested sequentially with BamHI (New England Biolabs) and Sst I (Bethesda Research Laboratories). Agarose gel electrophoresis, transfer to nitrocellulose filters, hybridization to the 32P-labeled EJ probe [a 6.6-kilobase (kb) BamHI EJ-specific fragment], and autoradiography were carried out using standard methods (18) . The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (17, 19) . Immunoprecipitation was carried out with 1.5 x 107 cpm of trichloroacetic acid-precipitable material using the rat monoclonal antibody preparation 238 (20) Plating efficiencies under anchorage-independent conditions were estimated as described (8, 11) , by culturing 102_105 cells in medium containing 1.3% methylcellulose, using 60-mm dishes coated with 0.6% agar. Cells were fed weekly, and macroscopic colonies were scored at 4.5 wk. Plating efficiencies on plastic were determined by inoculating 100 cells onto 60-mm dishes, which were stained and scored at 2 wk.
Assay of Tumor-Forming Ability in Athymic Mice. The tumorigenicity of various hybrids was compared with that of parental cells by using a modification of the coinjection method developed in our laboratory (10 (Fig. 3a, lane D) had three additional dark bands (heavy lines), 2.9, 2.2, and 0.8 kb in size. These bands arise because BamHI cuts the EJ gene from the transfected plasmid and because Sst I cuts three times within the EJ gene (Fig. 3b) . The largest band contains the complete coding sequence of the EJ gene as well as its normal promoter. The smallest band (best visualized in overexposed blots, not shown) consists of regions 5' to the coding sequence. Both of these bands appear intact in L3 and hybrid cells (Fig. 3a, lanes E-Z) , as determined by comparison with a BamHI/Sst I digest of plasmid DNA (lane A). The 3' region of the EJ gene (2.5-kb fragment in the plasmid) was shortened to 2.2 kb in the L3 cell line and its hybrid derivatives. However, this region does not contain structural sequences and is not translated. The copy number of the EJ gene in the hybrids was in the same range as in the L3 parent, as determined by quantitative Southern blot analysis. Thus, the L318 hybrids contain the entire coding sequence of the EJ gene as well as its 5' flanking region. No gross rearrangements appear to have occurred during cell fusion, as judged by these criteria.
Expression of EJ-Encoded p21 in L318 Hybrids. The two parental cell lines and several hybrids were tested for the presence of the p21 protein encoded by the EJ gene (Fig. 4) . As shown, the EJ-encoded p21 product was readily detectable in L3 The capacity of the hybrids for anchorage-independent growth was also intermediate between that of the two parents, as shown in Table 2 . Although the normal parent plated very poorly in methylcellulose, and the transformed parent plated very well (methylcellulose plating efficiency, >90%), the plating efficiencies of the hybrids ranged from <0.3% to 13%. L3 cells grown in methylcellulose for 4 wk formed readily visible colonies that were predominantly intermediate or large in size. Numerous microscopic colonies, which may represent satellites, were also observed. Colonies formed by the hybrid cell lines were variable in size, but, overall, were smaller than those formed by L3 (Table 2 ). These data show that L318 cell hybrids have a reduced capacity for anchorage-independent growth, both colony number and colony size being decreased below the value obtained with the transformed parent.
Tumor-Forming Ability of L318 Hybrids. The dm2 parent was nontumorigenic in nude mice, while the L3 parent consistently formed tumors (Table 3) . Tumor latency was 2-5 wk, death of the host generally occurring at 9-15 wk.
The hybrid cell lines were markedly less tumorigenic than the L3 parent. One hybrid (L318-45) did not form progressively growing tumors at any of seven sites assayed. With three additional hybrids (L318-1, L318-11, and L318-37), only a single tumor was formed out of five or six sites tested. Some hybrids formed slowly developing tumors: For example, L318-22 produced only two tumors out of seven sites tested, and these did not reach a size of >0.6 cm for [13] [14] wk. Most of the remaining hybrids were negative at 30-70% of the sites tested and developed tumors of long latency at some of the positive sites.
DISCUSSION
We have tested the ability of normal CHEF/18 cells to suppress transformation in an EJ-transfected CHEF/18 derivative. Our results show partial to complete inhibition of transformed morphology, anchorage independence, and tumor-forming ability in normal-tumor cell hybrids, consistent with the hypothesis that normal cells contain genes capable of suppressing the activated EJ oncogene. Since these effects occur in the presence of continued p21 expression, the suppressor gene products do not act by interfering with oncogene transcription or translation. Instead, they may interact with, modulate, or compete with the oncogene product or may act at a different point within a chain of events leading to transformation and tumorigenicity.
Chromosome studies (unpublished data) of the parental cells and hybrids revealed a translocation [t(3p;8q)] present in the L3 cells and in all of the hybrid lines. As yet no additional rearrangements have been found, nor are there nonrandom losses of particular chromosomes in the neartetraploid hybrid populations. These findings are consistent with other chromosome studies of suppressed hybrids (7) , showing that suppression is a property of the total hybrid genome.
The finding of suppression in oncogene-transformed CHEF/18 cells is consistent with data, from this laboratory and others, showing that fusion of normal and tumorigenic cells results in decreased tumorigenicity (7) . This phenomenon has been observed using tumor cells that are karyotypically normal, such as CHEF/16 (8) , as well as with highly aneuploid cells (21) . Suppression has been reported in simian virus 40-and avian sarcoma virus-transformed cells (9, 22) and in the HT-1080 cell line, which contains an activated N-ras gene (23) . An analogous loss of malignancy is seen in revertants of Kirsten murine sarcoma virus-transformed cells (24, 25) , and these cells can suppress transformation induced by related oncogenic viruses (24) . In this case, suppression occurs in the presence of continued expression of the viral transforming genes, paralleling the situation seen with hybrids of CHEF cell transfectants. Similarly, normal human fibroblasts that have been transfected with the EJ gene express high levels of p21, although they are not transformed in phenotype nor tumorigenic in nude mice (17) . (13, 26, 27) . Can the transforming effect of this gene in transfection experiments be reconciled with its suppressibility in cell hybrids?
The simplest hypothesis to invoke is that of competition between normal and mutant forms of the Ha-ras gene. L3 cells contain, on an average, one copy of the mutant EJ gene, which on this hypothesis is dominant over the two normal Ha-ras genes in L3, but not dominant over the four normal copies in the hybrids. Against this view is the evidence that normal Ha-ras driven by a strong promotor has the same transforming effect as the mutant gene (5) . The hypothesis we favor is that two classes of genes are involved: oncogenes that facilitate and anti-oncogenes that suppress the tumorigenic transformation. Thus, suppressor genes (i.e., anti-oncogenes) may have been lost or inactivated in the oncogene-transformed parent. This may have occurred prior to transfection (predisposing to focus formation), during oncogene integration, or in conjunction with subsequent genomic changes. In EJ-transfected CHEF/18 cells, for example, chromosome aberrations are seen frequently in focus-derived cells and invariably after tumor formation (unpublished data). Thus, we postulate that suppressor gene action has already been lost in L3 cells and subsequently is regained in hybrids by fusion with normal cells.
In conclusion, these data provide evidence for the existence of anti-oncogenes, whose gene products, when identified, may provide new agents for cancer therapy. In most somatic cell hybridization experiments carried out in the past, it was not possible to control, or even identify, the specific genetic loci active in the tumorigenic parent used. This resulted in the difficulty of attempting to study suppressor genes, active against transforming genes that were themselves unidentified. The use of a system, such as the one described here, in which defined sequences are implicated in tumor formation should greatly facilitate the isolation and characterization of suppressor genes.
